Lasa Supergenerics Limited (NSE: LASA) reported a net loss of ₹3,409.03 lakh for FY26, a significant increase from the net loss of ₹1,475.73 lakh recorded in FY25. The pharmaceutical manufacturer’s revenue from operations plummeted to ₹2,514.07 lakh, down sharply from ₹14,244.81 lakh in the prior year.

The company's operational status remains critical following a fire incident at its manufacturing facility on May 18, 2025. Consequently, production activities have been completely suspended. The Board of Directors highlighted that resuming operations is contingent upon obtaining statutory clearances and securing adequate financial resources.

Financial Performance

The decline in revenue was accompanied by substantial exceptional items, primarily due to uninsured losses from the fire. The company recognized an ad-hoc provisional impairment loss of ₹700 lakh on property, plant, and equipment, alongside inventory damage and other related expenses.

Exceptional items for the year totaled ₹2,103.75 lakh, compared to ₹1,566.91 lakh in FY25. These figures include the write-off of capital work-in-progress amounting to ₹46.27 lakh, which was deemed non-viable.

What the Numbers Show

The financial data reveals a severe liquidity contraction alongside operational paralysis. Liquid assets stood at just ₹69.66 lakh as of March 31, 2026, a decrease from ₹79.03 lakh in the previous year. With operations halted and no new revenue generation from manufacturing, the company is relying on asset disposals and borrowing to meet recurring expenditures and settle outstanding liabilities. Current borrowings rose significantly to ₹974.73 lakh from ₹212.75 lakh in FY25, indicating increased reliance on debt to manage cash flow constraints during this period of suspension.

Corporate Governance and Compliance

Lasa Supergenerics disclosed several regulatory non-compliances during FY26. The company failed to submit shareholding patterns, shareholder complaint statements, and quarterly corporate governance reports within the prescribed timelines for the quarter ended March 31, 2026. These delays resulted in penalties levied by both the National Stock Exchange and the Bombay Stock Exchange.

Additionally, the office of the Company Secretary remained vacant from August 29, 2025, to December 15, 2025, leading to non-compliance with SEBI Listing Regulations. Mrs. Mitti Jain was appointed as Company Secretary and Compliance Officer on December 16, 2025.

Board Changes

The company underwent significant changes in its key managerial personnel during the year. Mr. Prathamesh Chalke resigned as Whole-time Director on December 31, 2025. Mr. Ganesh Suresh Potdar served as an Additional Director from January 2, 2026, before resigning on August 25, 2026. Mr. Janardan Savala was appointed as an Additional Director on August 26, 2026, and is seeking approval for his appointment as Executive Director at the upcoming Annual General Meeting.

Auditor's Report

Statutory auditors Gupta Rustagi & Co. issued a qualified opinion on the financial statements. The qualification stems from the inability to determine the full financial impact of the fire incident due to incomplete assessment of damaged assets. Furthermore, the auditors noted that the company had not carried out impairment assessments for intangible assets, including patents and goodwill, despite indicators of impairment existing.